EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 21.02.2025 / 08:30 CET/CEST The issuer is
Evolva Holding SA / Key word(s): Annual Results 21-Feb-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer
Rancho Cucamonga, 02/20/2025 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. RANCHO CUCAMONGA, CA / ACCESS Newswire / February 20, 2025 / Amphastar
Issuer: Mainz BioMed N.V. / Key word(s): Alliance 20.02.2025 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed
Issuer: Immunic AG / Key word(s): Study results 20.02.2025 / 13:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic’s Oral
EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development 20.02.2025 / 13:00 CET/CEST The issuer
EQS-News: Formycon AG / Key word(s): Scientific publication Formycon presents clinical data on ustekinumab biosimilar FYB202 at the ECCO Congress in Berlin 20.02.2025 / 06:30
EQS-News: Nyxoah SA. / Key word(s): Market Launch Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East 19.02.2025 / 07:05 CET/CEST The issuer
Straumann Holding AG / Key word(s): Annual Results/Quarter Results 19-Feb-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The
Issuer: CureVac / Key word(s): Patent 18.02.2025 / 13:03 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Earns Repeat Recognition